Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1223 Views
-
Last post by frodo
-
- 0 Replies
- 899 Views
-
Last post by frodo
-
- 0 Replies
- 2132 Views
-
Last post by NHE
-
- 0 Replies
- 1194 Views
-
Last post by frodo
-
- 0 Replies
- 1100 Views
-
Last post by frodo
-
- 0 Replies
- 1133 Views
-
Last post by frodo
-
- 0 Replies
- 1316 Views
-
Last post by NHE
-
- 1 Replies
- 2731 Views
-
Last post by Tif
-
- 2 Replies
- 780 Views
-
Last post by DIM